View full meeting coverage »

Eyetube Meeting Coverage:

2018 Euretina Meeting

Replay

Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Trials on Steroids for Diabetic Eye Disease

Albert J. Augustin, MD

Channels: Retina | Posted 9/21/2018

Albert J. Augustin, MD, discusses the BEVORDEX trial, which compared bevacizumab (Avastin, Genentech) with the dexamethasone intravitreal implant 0.7 mg (Ozurdex, Allergan). Dr. Augustin also shares the results of studies that evaluated the efficacy of switching from anti-VEGF therapy to either the dexamethasone implant or the fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien, Alimera Science) in cases of recalcitrant disease.

Anti-VEGF • Diabetic macular edema, DME • Steroids

11 / 12 Series: 2018 Euretina Meeting

Albert J. Augustin, MD Channels: Retina | Posted 9/21/2018

Albert J. Augustin, MD, discusses the BEVORDEX trial, which compared bevacizumab (Avastin, Genentech) with the dexamethasone intravitreal implant 0.7 mg (Ozurdex, Allergan). Dr. Augustin also shares the results of studies that evaluated the efficacy of switching from anti-VEGF therapy to either the dexamethasone implant or the fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien, Alimera Science) in cases of recalcitrant disease.

Keywords

Anti-VEGF • Diabetic macular edema, DME • Steroids

Comments view all

. United States - today

Post Comment
post as anonymous

More Videos in this Series

1

Understanding the ALTAIR Study

Masahito Ohji, MD

Three Exciting New Drugs

Pravin U. Dugel, MD

Value of Recent Surgical Innovations

José García-Arumí, MD, PhD

The One Thing Every Doctor Can Do to Imp…

Nadia K. Waheed, MD, MPH, Pravin U. Dugel, MD

Disrupted Imaging on OCTA

Nadia K. Waheed, MD, MPH

Micropulse Laser in BRVO

Matteo Forlini, MD

Gene Therapy in Retinitis Pigmentosa

Robert E. MacLaren, MB, ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Can We Get Smaller Than 27-Gauge Instrum…

José García-Arumí, MD, PhD, Robert E. MacLaren, MB, ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Can Technology Lead to a Seamless Diagno…

William Tucker, MD

Management of RVO

Anat Loewenstein, MD

Trials on Steroids for Diabetic Eye Dise…

Albert J. Augustin, MD

Is There Any Hope for Dry AMD Patients?

Anat Loewenstein, MD, William Tucker, MD

View full meeting coverage (12 videos)

1

Is There Any Hope for Dry AMD Patients?

Anat Loewenstein, MD, William Tucker, MD